BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 21156040)

  • 21. The positive association of branched-chain amino acids and metabolic dyslipidemia in Chinese Han population.
    Yang P; Hu W; Fu Z; Sun L; Zhou Y; Gong Y; Yang T; Zhou H
    Lipids Health Dis; 2016 Jul; 15():120. PubMed ID: 27457614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study.
    Ozder A
    Lipids Health Dis; 2014 Dec; 13():183. PubMed ID: 25481115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of arterial stiffness and diabetes with triglycerides-to-HDL cholesterol ratio for Japanese men: the Nagasaki Islands Study.
    Shimizu Y; Nakazato M; Sekita T; Kadota K; Yamasaki H; Takamura N; Aoyagi K; Maeda T
    Atherosclerosis; 2013 Jun; 228(2):491-5. PubMed ID: 23601500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Triglyceride/HDL Ratio and Triglyceride Glucose Index as Predictors of Glycemic Control in Patients with Diabetes Mellitus Type 2.
    Babic N; Valjevac A; Zaciragic A; Avdagic N; Zukic S; Hasic S
    Med Arch; 2019 Jun; 73(3):163-168. PubMed ID: 31404127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erosive esophagitis associated with metabolic syndrome, impaired liver function, and dyslipidemia.
    Loke SS; Yang KD; Chen KD; Chen JF
    World J Gastroenterol; 2013 Sep; 19(35):5883-8. PubMed ID: 24124334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PROMETHEUS: an observational, cross-sectional, retrospective study of hypertriglyceridemia in Russia.
    Karpov Y; Khomitskaya Y
    Cardiovasc Diabetol; 2015 Aug; 14():115. PubMed ID: 26303403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Independent association of atherogenic dyslipidaemia with all-cause mortality in individuals with type 2 diabetes and modifying effect of gender: a prospective cohort study.
    Orsi E; Penno G; Solini A; Bonora E; Fondelli C; Trevisan R; Vedovato M; Cavalot F; Morano S; Baroni MG; Nicolucci A; Pugliese G;
    Cardiovasc Diabetol; 2021 Jan; 20(1):28. PubMed ID: 33516215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-density lipoprotein cholesterol-to-apolipoprotein B ratio as a potential indicator of LDL particle size and plasma atherogenicity in type 2 diabetes.
    Viktorinova A; Malickova D; Svitekova K; Choudhury S; Krizko M
    Diabetes Res Clin Pract; 2021 Jun; 176():108858. PubMed ID: 34015391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Prevalence of Vitamin D Deficiency and Correlation of Serum Vitamin D with Cardiovascular Risk in Patients with Metabolic Syndrome.
    Alkhatatbeh MJ; Abdul-Razzak KK; Khasawneh LQ; Saadeh NA
    Metab Syndr Relat Disord; 2017 Jun; 15(5):213-219. PubMed ID: 28346853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals in Hungary.
    Mark L; Vallejo-Vaz AJ; Reiber I; Paragh G; Kondapally Seshasai SR; Ray KK
    Atherosclerosis; 2015 Jul; 241(1):62-8. PubMed ID: 25966441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Status of lipid control in Bangladeshi subjects with type 2 diabetes mellitus on lipid-lowering drugs: a multicenter, facility-based, cross-sectional study.
    Selim S; Alam MS; Talukder SK; Kabir ML; Gaffar AJ; Kabir MA; Zarin N; Rahman S; Nabi MMU; Mustari M; Hossain MF; Raunak AIB; Hoque MA; Islam MR; Akter F; Hannan MA; Saifuddin M; Asaduzzaman M; Rahman MM; Ahammed A; Rafi MA; Hasan MJ; Kamrul-Hasan ABM
    BMC Endocr Disord; 2023 Dec; 23(1):268. PubMed ID: 38053073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome.
    Bianchi C; Penno G; Malloggi L; Barontini R; Corfini M; Giovannitti MG; Di Cianni G; Del Prato S; Miccoli R
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):31-8. PubMed ID: 17420118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence.
    Hermans MP; Sacks FM; Ahn SA; Rousseau MF
    Cardiovasc Diabetol; 2011 Feb; 10():20. PubMed ID: 21356116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus.
    Toth PP; Simko RJ; Palli SR; Koselleck D; Quimbo RA; Cziraky MJ
    Cardiovasc Diabetol; 2012 Sep; 11():109. PubMed ID: 22978715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic markers associated with insulin resistance predict type 2 diabetes in Koreans with normal blood pressure or prehypertension.
    Sung KC; Park HY; Kim MJ; Reaven G
    Cardiovasc Diabetol; 2016 Mar; 15():47. PubMed ID: 27001495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative.
    Russo GT; De Cosmo S; Viazzi F; Pacilli A; Ceriello A; Genovese S; Guida P; Giorda C; Cucinotta D; Pontremoli R; Fioretto P;
    Diabetes Care; 2016 Dec; 39(12):2278-2287. PubMed ID: 27703024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Components of metabolic syndrome and 5-year change in insulin clearance - the Insulin Resistance Atherosclerosis Study.
    Lee CC; Lorenzo C; Haffner SM; Wagenknecht LE; Goodarzi MO; Stefanovski D; Norris JM; Rewers MJ; Hanley AJ
    Diabetes Obes Metab; 2013 May; 15(5):441-7. PubMed ID: 23216702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
    Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
    Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of the Triglyceride/High-Density Lipoprotein Cholesterol Index with Insulin Resistance in a Pediatric Population in Northeast Mexico.
    Rodríguez-Gutiérrez N; Vanoye Tamez M; Vázquez-Garza E; Villarreal-Calderón JR; Castillo EC; Laresgoiti-Servitje E; Elizondo-Montemayor L; García-Rivas G
    Metab Syndr Relat Disord; 2020 Sep; 18(7):333-340. PubMed ID: 32552368
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.